Fig. 2.
Response to treatment in a patient with mild hemophilia A and an acquired FVIII inhibitor.
Upper half of the figure shows percentage of FVIII activity (FVIIIc). Lower half shows inhibitor titer in Bethesda units. Rituximab 375 mg/m2 (open arrows) was given at week 0 and week 1. Prednisone at 1 mg/kg/d is indicated by a solid line; broken line indicates prednisone taper.
